Oct 12 (Reuters) - U.S. health officials said on Friday they requested a strong “black box” warning on Bristol-Myers Squibb Co’s (BMY.N: Quote, Profile, Research) Definity and General Electric Co’s (GE.N: Quote, Profile, Research) Optison about reports of serious cardiopulmonary reactions after people were injected with the imaging agents.
